Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexmedetomidine As an Effective Drug in Reducing Anesthetic Requirements in Patients Undergoing External Dacrocystorhinostomy, a Randomized Controlled Study

NCT06808295 is registered in ClinicalTrials.gov with Research Institute of Ophthalmology, Egypt as lead sponsor.

NCT NCT06808295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06808295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexmedetomidine As an Effective Drug in Reducing Anesthetic Requirements in Patients Undergoing External Dacrocystorhinostomy, a Randomized Controlled Study
Lead sponsor
Research Institute of Ophthalmology, Egypt
Phase
Phase 1
Overall status
Recruiting
Start date
April 16, 2024
Completion date
May 31, 2025
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

assess decreased anesthetic requirements intraoperative, patients undergoing external dacrocystorhinostomy operations